helix tirzepatide Biopharma successfully out-licenses late stage Biphasix technology Tirzepatide Flex-Dose 1 mL Injectable

462 Compared with placebo, long-term administration (e.g., 25 mg or 100 mg every 8 h for 12 weeks) significantly decreased mPAP and improved the 6 min walk distance, with good tolerability

Our approach blends advanced GLP-1 therapies with compassionate, individualized care

Regular monitoring may be appropriate to ensure your emotional wellbeing is maintained throughout treatment

Your doctor can check your levels with a simple blood test

Tirzepatide induces ferroptosis in glioblastoma cell lines via the SOX2/SLC7A11 axis: a potential therapeutic strategy for glioma treatment

Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk